News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar
Photo from Alfredo Rivas-Delgado/X
Apr 29, 2024, 00:54

Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar

Alfredo Rivas-Delgado, Research Fellow at Memorial Sloan Kettering Cancer, posted on X/Twitter:

“A comprehensive review on treating high-risk MCL patients by Anita Kumar

– High Ki67, TP53mut, blastoid morphology, POD24
– Targeted therapy including BTKi + BCL2inh + antiCD20
– Promising data with CAR-T and BsAbs
– Refer early to tertiary centers.“

Source: Alfredo Rivas-Delgado/X

Alfredo Rivas-Delgado Anita Kumar blastoid morphology cancer CAR-T and BsAbs High Ki67 high-risk MCL patients OncoDaily Oncology POD24 targeted therapy tertiary centers TP53mut
Special Coverage
Blog
Nov 18, 2024, 16:50
Cervical Cancer Elimination Day of Action 2024 - Medicaid Cancer Foundation
Blog
Nov 18, 2024, 16:50
Michael Duruisseaux: Prognostic value of neutrophil to lymphocyte ratio before adjuvant durvalumab in locally advanced NSCLC
Blog
Nov 18, 2024, 16:39
Cristiane Bergerot: Psycology Society suffering in patients with cancer remains a worldwide unmet need
Insight
Nov 18, 2024, 16:36
Very last chance to apply for the CancerX Accelerator Startup
Insight
Nov 18, 2024, 16:31
Andreas Koulouris: Incredible opportunity to participate in the Lung Cancer Preceptorship in Paris
Insight
Nov 18, 2024, 16:04
Manlio Vinciguerra: Circulating histone signature of Diffuse Intrinsic Pontine Glioma
Insight
Nov 18, 2024, 15:58
Petros Grivas: Fantastic experience to present at WA medical oncology society
Opinion
Nov 18, 2024, 15:57
Marking 4 years of WHO's Cervical Cancer Elimination movement - IARC
Insight
Nov 18, 2024, 15:52
The 15th ENGOT Gynaecological Cancer Academy workshop
Blog
Nov 18, 2024, 15:33
Sami Mansfield: Cancer doesn’t wait. Neither should we
Insight
Nov 18, 2024, 15:30
Gustavo Viani: Radiotherapy with durvalumab vs cetuximab advanced HNSCC
Insight
Nov 18, 2024, 15:27
Sahar Mansour: The Hidden Challenge in Breast Imaging